• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量静脉注射阿糖胞苷成功治疗恶性淋巴瘤所致脑实质受累

Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma.

作者信息

Frick J C, Hansen R M, Anderson T, Ritch P S

出版信息

Arch Intern Med. 1986 Apr;146(4):791-2.

PMID:3963961
Abstract

A patient with systemic recurrence of large-cell malignant lymphoma developed radiologic evidence of parenchymal brain metastasis. Treatment with systemic high-dose cytarabine resulted in complete regression of peripheral adenopathy and complete radiologic response in the central nervous system, with normalization of the brain computed tomographic scan. This case further demonstrates the ability of high-dose cytarabine to penetrate the blood-brain barrier and achieve therapeutic drug concentrations in the central nervous system, an area that might otherwise remain a pharmacologic sanctuary for tumor cells.

摘要

一名患有大细胞恶性淋巴瘤全身复发的患者出现了脑实质转移的影像学证据。全身大剂量阿糖胞苷治疗导致外周淋巴结病完全消退,中枢神经系统出现完全的影像学反应,脑部计算机断层扫描恢复正常。该病例进一步证明了大剂量阿糖胞苷穿透血脑屏障并在中枢神经系统达到治疗药物浓度的能力,否则该区域可能仍是肿瘤细胞的药物庇护所。

相似文献

1
Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma.大剂量静脉注射阿糖胞苷成功治疗恶性淋巴瘤所致脑实质受累
Arch Intern Med. 1986 Apr;146(4):791-2.
2
A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗急性白血病和难治性淋巴瘤的初步研究:临床反应与药理学
Cancer Res. 1982 Apr;42(4):1587-94.
3
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
4
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.放疗联合阿糖胞苷化疗治疗散发性原发性中枢神经系统淋巴瘤后的长期生存情况
Strahlenther Onkol. 2003 Sep;179(9):626-32. doi: 10.1007/s00066-003-1083-3.
5
Management of Burkitt's lymphoma involving the central nervous system.
Afr J Med Med Sci. 1976 Jun;5(2):121-4.
6
Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.儿童和青少年晚期大细胞淋巴瘤:一项随机试验的结果,该试验在APO方案维持期纳入了中剂量甲氨蝶呤和高剂量阿糖胞苷:一项儿科肿瘤学组III期试验
J Clin Oncol. 2005 Jan 20;23(3):541-7. doi: 10.1200/JCO.2005.11.075.
7
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.脂质体阿糖胞苷治疗淋巴瘤累及中枢神经系统患者的疗效与安全性
Cancer. 2009 May 1;115(9):1892-8. doi: 10.1002/cncr.24204.
8
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.黄斑病变作为中枢神经系统淋巴瘤患者血脑屏障破坏的并发症。
Am J Ophthalmol. 2007 Jul;144(1):45-49. doi: 10.1016/j.ajo.2007.03.057.
9
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.原发性中枢神经系统淋巴瘤:化疗后采用输注溴脱氧尿苷联合全脑加速分割放射治疗的I期评估
Cancer. 2003 Sep 1;98(5):1021-8. doi: 10.1002/cncr.11627.
10
[Chemotherapy of primary cerebral lymphoma].[原发性脑淋巴瘤的化疗]
Neurochirurgie. 1997;43(6):380-4.

引用本文的文献

1
Metastatic neurologic complications of non-Hodgkin's lymphoma.非霍奇金淋巴瘤的转移性神经并发症
Curr Oncol Rep. 2005 Jan;7(1):55-60. doi: 10.1007/s11912-005-0026-9.
2
Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?最初诊断为原发性中枢神经系统淋巴瘤(PCNSL)的患者中隐匿性系统性非霍奇金淋巴瘤(NHL):分期到何种程度足够?
J Neurooncol. 1995;25(1):67-71. doi: 10.1007/BF01054724.
3
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.
Cancer Chemother Pharmacol. 1992;29(3):173-7. doi: 10.1007/BF00686248.
4
Primary central nervous system lymphomas--an update.原发性中枢神经系统淋巴瘤——最新进展
J Cancer Res Clin Oncol. 1992;119(1):7-27. doi: 10.1007/BF01209483.